Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-22

Clinical Trial Update: The Efficacy and Treatment Adherence With an Integrated Program on HbA1c Scores in Patients With Type 2 Diabetes [NA]

View source ↗

Summary

Completed clinical trial evaluating the efficacy and treatment adherence of an integrated program on HbA1c levels in patients with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: KRJG Services Inc. | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED